MARKET

BIOL

BIOL

BIOLASE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4415
+0.0021
+0.48%
Opening 12:13 08/11 EDT
OPEN
0.4450
PREV CLOSE
0.4394
HIGH
0.4590
LOW
0.4351
VOLUME
6.15M
TURNOVER
--
52 WEEK HIGH
1.558
52 WEEK LOW
0.2110
MARKET CAP
22.23M
P/E (TTM)
-0.5959
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BIOL stock price target is 2.383 with a high estimate of 3.500 and a low estimate of 1.650.

EPS

BIOL News

More
BIOLASE Filing Shows Registration For 18.62M Share Common Stock Offering
Benzinga · 07/24 10:03
BIOLASE Announces Closing Of Oversubscribed Rights Offering
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet today as it closed the Company's previously announced rights offering (the "Offering"). At the closing, BIOLASE issued and sold an aggregate of 18,000 shares
PR Newswire · 07/22 20:05
BIOLASE's oversubscribed rights offering expires
BIOLASE (BIOL -5.9%) announced expiration of its oversubscribed (229%) rights offering on July 15, 2020; subscriptions totaled 49,375 units. Units at a sub
seekingalpha · 07/16 21:11
BIOLASE Announces Expiration Of Oversubscribed Rights Offering
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, announced today the expiration of the Company's rights offering, which was oversubscribed. The subscription period for its previously announced rights offering (the "Offering") of units at a subsc
PR Newswire · 07/16 10:30
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in an Era of COVID-19, presented by Maxim Group and M-Vest on T
PR Newswire · 07/09 10:30
BIOLASE's Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission
PR Newswire · 07/08 14:00
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period
PR Newswire · 07/02 11:30
BIOLASE Reports Commencement Of Rights Offering Subscription Period
BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If exercising subscription rights through a broker, dealer, bank or other
Benzinga · 07/02 10:30

Industry

Advanced Medical Equipment & Technology
0.00%
Healthcare Equipment & Supplies
+0.15%

Hot Stocks

Symbol
Price
%Change

About BIOL

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
More

Webull offers kinds of BIOLASE Inc stock information, including NASDAQ:BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOL stock methods without spending real money on the virtual paper trading platform.